Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Lo

Showing results (331-340 of 386) with videos related to

Pageof 39
Sort By:
Trials|August 7, 2019
Whole brain radiotherapy (WBRT) after local treatment of brain metastases in melanoma patients: Statistical Analysis PlanSerigne N Lo, Angela M Hong, Lauren E Haydu, et al.
Journal of the American Academy of Dermatology|July 19, 2025
Radiotherapy versus imiquimod for complex lentigo maligna: A phase 3 randomized clinical trialAngela M Hong, Serigne N Lo, Gerald B Fogarty, et al.
Journal for Immunotherapy of Cancer|January 31, 2024
Management of infliximab refractory immune checkpoint inhibitor gastrointestinal toxicity: a multicenter case seriesCatriona Harvey, Kazi J Nahar, Janet McKeown, et al.
European Journal of Cancer (Oxford, England : 1990)|December 12, 2022
BRAF inhibitor cessation prior to disease progression in metastatic melanoma: Long-term outcomesJoanna Lee, Tasnia Ahmed, Andrea Maurichi, et al.
Cancer Immunology Research|September 12, 2020
Tumor Mutation Burden and Structural Chromosomal Aberrations Are Not Associated with T-cell Density or Patient Survival in Acral, Mucosal, and Cutaneous MelanomasJarem Edwards, Peter M Ferguson, Serigne N Lo, et al.
Breast (Edinburgh, Scotland)|July 5, 2016
Don't forget the dentist: Dental care use and needs of women with breast cancerDeborah N N Lo-Fo-Wong, Hanneke C J M de Haes, Neil K Aaronson, et al.
Annals of Surgical Oncology|May 18, 2024
The Effect of Neoadjuvant Systemic Therapy on Surgical Outcomes After Lymph Node Dissections for Stage III Melanoma; An Australian CohortLisanne P Zijlker, Henry Chen, Andrew J Spillane, et al.
Breast Cancer Research and Treatment|July 16, 2016
Predictors of enduring clinical distress in women with breast cancerDeborah N N Lo-Fo-Wong, Hanneke C J M de Haes, Neil K Aaronson, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 25, 2021
Large-scale plasma proteomic profiling identifies a high-performance biomarker panel for Alzheimer's disease screening and stagingYuanbing Jiang, Xiaopu Zhou, Fanny C Ip, et al.
European Journal of Cancer (Oxford, England : 1990)|September 18, 2025
A dynamic recurrence risk prediction tool for adjuvant therapy in stage III melanomaAndrea Boutros, Amelia M Taylor, Isabel Li, et al.
Pageof 39

Showing results (331-340 of 386) with videos related to

Sort By:
Pageof 39
Trials|August 7, 2019
Whole brain radiotherapy (WBRT) after local treatment of brain metastases in melanoma patients: Statistical Analysis PlanSerigne N Lo, Angela M Hong, Lauren E Haydu, et al.
Journal of the American Academy of Dermatology|July 19, 2025
Radiotherapy versus imiquimod for complex lentigo maligna: A phase 3 randomized clinical trialAngela M Hong, Serigne N Lo, Gerald B Fogarty, et al.
Journal for Immunotherapy of Cancer|January 31, 2024
Management of infliximab refractory immune checkpoint inhibitor gastrointestinal toxicity: a multicenter case seriesCatriona Harvey, Kazi J Nahar, Janet McKeown, et al.
European Journal of Cancer (Oxford, England : 1990)|December 12, 2022
BRAF inhibitor cessation prior to disease progression in metastatic melanoma: Long-term outcomesJoanna Lee, Tasnia Ahmed, Andrea Maurichi, et al.
Cancer Immunology Research|September 12, 2020
Tumor Mutation Burden and Structural Chromosomal Aberrations Are Not Associated with T-cell Density or Patient Survival in Acral, Mucosal, and Cutaneous MelanomasJarem Edwards, Peter M Ferguson, Serigne N Lo, et al.
Breast (Edinburgh, Scotland)|July 5, 2016
Don't forget the dentist: Dental care use and needs of women with breast cancerDeborah N N Lo-Fo-Wong, Hanneke C J M de Haes, Neil K Aaronson, et al.
Annals of Surgical Oncology|May 18, 2024
The Effect of Neoadjuvant Systemic Therapy on Surgical Outcomes After Lymph Node Dissections for Stage III Melanoma; An Australian CohortLisanne P Zijlker, Henry Chen, Andrew J Spillane, et al.
Breast Cancer Research and Treatment|July 16, 2016
Predictors of enduring clinical distress in women with breast cancerDeborah N N Lo-Fo-Wong, Hanneke C J M de Haes, Neil K Aaronson, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 25, 2021
Large-scale plasma proteomic profiling identifies a high-performance biomarker panel for Alzheimer's disease screening and stagingYuanbing Jiang, Xiaopu Zhou, Fanny C Ip, et al.
European Journal of Cancer (Oxford, England : 1990)|September 18, 2025
A dynamic recurrence risk prediction tool for adjuvant therapy in stage III melanomaAndrea Boutros, Amelia M Taylor, Isabel Li, et al.
Pageof 39